A/Prof Gerry Hanna is the Director of Radiation Oncology at the Peter MacCallum Cancer Centre, Melbourne and holds an honorary appointment with the University of Melbourne.
Dr Hanna completed his undergraduate training at Queen’s University Belfast and his post graduate training at the Cancer Centre, Belfast City Hospital. Following his PhD fellowship, Dr Hanna was awarded the Royal College of Radiologists’ Keith Durrant Memorial Travelling Fellowship to undertake a fellowship at the Vrije University Medical Centre in Amsterdam. Prior to taking up his current post, Dr Hanna was a Clinical Senior Lecturer and Consultant in Radiation Oncology at Queen’s University Belfast.
His Research interests include the use of PET/CT in radiotherapy planning for lung cancer, mechanisms of radiotherapy resistance, stereotactic ablative radiotherapy and systemic therapy and immunotherapy combinations with radiotherapy. He is the chief investigator of the International Atomic Energy Agency’s “PERTAIN” study.
He is the Thoracic Sub-Study lead for the SARON study and a TMG member for the UK’s HALT, CONFIRM and CONCORDE studies.
- St. Luke’s Medal, Royal College of Surgeons of Ireland, Dublin, 2007.
- Keith Durrant Memorial Travelling Fellowship, Royal College of Radiologists, London 2009.
- Pearl Ewing Travelling Fellowship, Friends of the Cancer Centre, Belfast, N. Ireland, 2009.
- Best Post-Graduate Research Prize, Faculty of Medicine, Annual Celebration of Excellence, Queen’s University Belfast 2011.
- UK National Quality in Care Oncology Award 2016